During the corresponding time, Impact Biomedical Inc. saw a revenue deteriorated by -57.14 % year on year, sequentially revenue fell by -57.14 %. While revenue at the Impact Biomedical Inc.'s corporate clients
Impact Biomedical's Comment on Sales, Marketing and Customers
Impact BioMedical's business model involves licensing and potential direct sales for commercialization and distribution. Potential licensors and development partners include pharmaceutical, food, and consumer packaged goods companies. The company focuses on drug discovery and the prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. Additionally, it is developing open-air defense initiatives aimed at reducing the transmission of airborne infectious diseases such as tuberculosis and influenza.
Impact Biomedical’s Comment on Sales, Marketing and Customers
Impact BioMedical's business model involves licensing and potential direct sales for commercialization and distribution. Potential licensors and development partners include pharmaceutical, food, and consumer packaged goods companies. The company focuses on drug discovery and the prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. Additionally, it is developing open-air defense initiatives aimed at reducing the transmission of airborne infectious diseases such as tuberculosis and influenza.
Sources:
IMPACT BIOMEDICAL INC.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: IMPACT BIOMEDICAL INC.’s corporate clients.
For your research, we’ve provided 9 tables on IMPACT BIOMEDICAL INC. corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
333.33 %